Dual diagnosis treatment for Hollywood — substance use and mental health, together.

RECO runs a single integrated team — addiction psychiatry, master's-level therapists, and trauma-trained clinicians — treating substance use and co-occurring mental health diagnoses concurrently rather than sequentially. For Hollywood clients, the 50-minute drive up I-95 to Delray, combined with on-site sober-living, creates the geographic separation from active-use environments that early dual diagnosis recovery generally requires.

The drive from Hollywood to Delray Beach runs 35 miles up I-95, about 50 minutes outside the rush windows that build along Sheridan Street and the I-595 interchange. Most clients we admit from Hollywood Beach, Emerald Hills, and Hollywood Lakes don’t make that drive twice a day. They combine PHP with on-site sober-living in Delray, and the distance does clinical work — it puts physical space between treatment and the dealer, the bar, the apartment, the relationships tied to active use. For someone carrying both a substance use disorder and an untreated mental health diagnosis, that separation is often the variable that lets the rest of the work hold.

RECO Intensive runs an integrated dual diagnosis program — not a substance use program with a psychiatric add-on, but a single clinical structure where the addiction medicine team and the mental health team treat the same person in the same week, with shared notes, shared treatment planning, and shared accountability. In-house addiction psychiatry handles medication. Master’s-level therapists address both diagnoses in every session. The two never get handed off.

Why integrated treatment outperforms sequential

For three decades, the standard pattern in American behavioral health was sequential: detox first, then substance use treatment, then — if symptoms persisted — referral out to a mental health provider. The research on outcomes has been unambiguous for nearly as long. Sequential care produces worse outcomes than integrated care across nearly every measure that matters: relapse rates, psychiatric hospitalization, treatment retention, and functional recovery at twelve months.

The mechanism is intuitive. When someone with major depression completes a 30-day rehab and is then told to “follow up with a psychiatrist,” the untreated depression doesn’t politely wait. It drives the early-recovery thoughts that lead back to use within weeks. The same pattern plays out with anxiety, PTSD, and bipolar disorder. Treating one diagnosis while ignoring the other is, in practice, treating neither. RECO’s partial hospitalization program and intensive outpatient program are both built on the assumption that both diagnoses get worked on, in parallel, by the same team.

The conditions most commonly co-occurring with substance use disorder

Roughly half of people with a substance use disorder meet criteria for at least one other psychiatric diagnosis at some point. The conditions cluster predictably: major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder, bipolar disorder, and ADHD account for the large majority of co-occurring presentations RECO sees. Each is assessed at admission using structured clinical interviews, not just self-report, and each has a defined treatment pathway.

• Major depression and persistent depressive disorder — CBT and behavioral activation as primary modalities, with SSRIs or SNRIs when medication is indicated. Alcohol use disorder is the most common substance pairing here; we often add naltrexone or acamprosate to the regimen.
• Generalized and social anxiety disorder — CBT and exposure-based work in individual and group settings. Benzodiazepines are generally avoided in this population for obvious reasons; non-addictive alternatives are used.
• PTSD and complex trauma — covered in its own section below.
• Bipolar I and II — psychiatric medication management is non-negotiable. Mood stabilization comes first; therapy targets the patterns of use that emerge during hypomanic and depressed phases.
• ADHD — particularly common alongside stimulant and cannabis use disorders. Non-stimulant treatment options are typically used in early recovery, with re-evaluation later in care.

Trauma-focused therapy as a core modality

A large share of substance use is downstream of unprocessed trauma. That includes capital-T trauma — sexual assault, combat exposure, childhood abuse — but also the more diffuse developmental trauma that doesn’t make it into a chart unless someone asks the right questions. RECO’s clinical team is trained in Trauma-Focused CBT and EMDR, and group facilitators run process groups under trauma-informed protocols. The point isn’t to make trauma the only frame, but to keep it on the table — because treating use without addressing the thing the use was solving for is a short-term intervention.

EMDR in particular has a substantial evidence base for PTSD, and we use it actively once a client has enough stabilization in early recovery to tolerate the work. Trauma-Focused CBT is paced more gradually and integrates well with the standard CBT and DBT skills work clients are already doing. For clients whose trauma history is severe, we may extend the length of stay or step down through residential care first to give the work a safer container.

In-house psychiatry coordinated with therapy

The single biggest failure mode in dual diagnosis care is fragmentation: a prescriber in one office who never talks to the therapist in another office, medication changes that the therapist learns about three weeks later, and no shared treatment plan. RECO’s psychiatry team works on-site. A medication change discussed Tuesday morning is in the therapist’s hands by the Tuesday afternoon session. Concerns the therapist surfaces — sleep collapse, hypomanic markers, suicidal ideation — go to the prescriber that same day.

For substance use itself, the medication options are evidence-based and matched to the substance: naltrexone (oral or Vivitrol injection) and acamprosate for alcohol use disorder; buprenorphine for opioid use disorder, coordinated through licensed prescribers; naltrexone again for opioid maintenance in clients who prefer non-agonist treatment. ASAM criteria across all six dimensions guide the level-of-care decision — biomedical, emotional/behavioral, readiness, relapse potential, recovery environment, and acute intoxication/withdrawal — so the placement reflects clinical reality rather than insurance defaults.

Coverage, logistics, and how Hollywood clients usually start

RECO is in-network with most major commercial carriers — Aetna, Cigna, Blue Cross Blue Shield, United Behavioral Health, Magellan, and others. We don’t accept Medicaid or Medicare. The insurance verification page runs benefits in roughly the time it takes to finish a phone call, including the specific behavioral health and substance use benefit details that matter for dual diagnosis coverage. Out-of-network options exist for plans that don’t have a direct contract.

For Hollywood-area clients, the typical pathway is a phone screen, a clinical assessment (often by video the same day), insurance verification, and admission within 24-72 hours. Most arrive at PHP and move into RECO sober-living in Delray for the duration of PHP and IOP, then step down to aftercare and alumni programming when they’re ready to return to Hollywood. Alcohol-specific programming details are on the alcohol addiction treatment page; opioid-specific details, including buprenorphine protocols, are on the heroin and opioid addiction treatment page.

Serving residents of: Hollywood Beach, Emerald Hills, Hollywood Lakes, Hollywood Hills, Oakwood.